Appendices 1-18 to: Report on the Health Effects of Selected Pesticide Coformulants

135     References

At (2002). Grænseværdier for stoffer og materialer. Arbejdstilsynets At-vejledning C.0.1, oktober 2002.

Beaulieu HJ and Schmerber KR (1991). M-PyrolÔ (NMP) use in the microelectronics industry. Appl Occup Environ Hyg 6, 874-880.

Fries AS, Hass U, Jakobsen BM, Jelnes JE, Lund SP and Simonsen L (1992). N-methylpyrrolidons effekter på fosterudvikling, centralnerve­system, testikler og sæd hos rotter. Arbejdsmiljøfondet, København.

Hass U, Jakobsen BM and Lund SP (1995). Developmental toxicity of inhaled N-methylpyrrolidone in the rat. Pharmacol Toxicol 76, 406-509.

Hass U, Lund SP and Elsner J (1994). Effects of prenatal exposure to N-methylpyrrolidone on postnatal development and behaviour in rats. Neurotoxicol Teratol 16, 241-249.

HSDB (2001). 1-Methyl-2-pyrrolidinone. In: Hazardous Substances Data Base.

IUCLID (2000). 1-Methyl-2-pyrrolidone. In: International Uniform Chemical Information Database. Existing Chemicals 2000. ECB, JCR, Ispra.

Lee KP, Chromey NC, Culik R, Barnes JR and Schneider PW (1987). Toxicity of N-methyl -2-pyrrolidone (NMP): Teratogenic, subchronic and two-year inhalation studies. Fundam Appl Toxicol 9, 222-235.

Malley LA, Kennedy GL, Elliott GS, Slone TW, Mellert W, Deckardt K, Gembardt C, Hildebrand B, Parod RJ, McCarthy TJ and Griffiths JC (1999). 90-Day subchronic toxicity study in rats and mice fed N-methylpyrrolidone (NMP) including neurotoxicity evaluation in rats. Drug Chem Toxicol 22, 455-480.

Merck Index (1996). 1-Methylyrrolidone. 12th.  ed., Rahway, New Jersey, Merck & Co., Inc., 1043.

Midgley I, Hood AJ, Chasseaud LF, Brindley CJ, Baughman S and Allan G (1992). Percutaneous absorption of co-administered N-methyl-2-[14C]pyrrolidinone and 2-[14C] pyrrolidinone in the rat. Fd Chem Toxicol 30, 57-64.

MM (2002). The Statutory Order from the Ministry of the Environment no. 439 of June 3, 2002, on the List of Chemical Substances.

MST (1990). Begrænsning af luftforurening fra virksomheder. Vejled­ning fra Miljøstyrelsen nr. 6 1990.

Saillenfait AM, Gallissot F and Morel G (2003). Developmental toxicity of N-methyl-2-pyrrolidone in rats following inhalation exposure. Fd Chem Toxicol 41, 583-588.

 

Solomon GM, Morse EP, Garbo MJ and Milton DK (1996). Stillbirth after occupational exposure to N-methyl-2-pyrrolidone. J Occup Environ Med 38, 705-713.

TOXLINE PLUS 1999-2000/01.

Trochimowicz HL et al. (1994). N-methyl-2-pyrrolidinone. In: Clayton GD, Clayton FE eds. Patty‘s Industrial Hygiene and Toxicology, 4th. ed. John Wiley & Sons, Inc, Vol IIE, 3309-3312.

Wells DA and Digenis GA (1988). Disposition and metabolism of double-labeled [3H and 14C] N-methyl-2-pyrrolidinone in the rat. Drug Metab Disp 16, 243-249.

Åkesson B (1994). N-Methyl-2-pyrrolidone (NMP). Arbete och Hälsa 1994:40. Nordic Expert Group for Criteria Documentation of Health Risks from chemicals. Arbetarskyddsverket.

Åkesson B and Paulsson K (1997). Experimental exposure of male volunteers to N-methyl-2-pyrrolidone (NMP): acute effects and pharmacokinetics of NMP in plasma and urine. Occup Environ Med 54, 236-240.